Application of Genomic Data in Translational Medicine During the Big Data Era

Yun Zhang,Jian Yu,Xiaoyan Xie,Feng Jiang,Chuyan Wu
DOI: https://doi.org/10.31083/j.fbl2901007
2024-01-12
Abstract:Advances in gene sequencing technology and decreasing costs have resulted in a proliferation of genomic data as an integral component of big data. The availability of vast amounts of genomic data and more sophisticated genomic analysis techniques has facilitated the transition of genomics from the laboratory to clinical settings. More comprehensive and precise DNA sequencing empowers patients to address health issues at the molecular level, facilitating early diagnosis, timely intervention, and personalized healthcare management strategies. Further exploration of disease mechanisms through identification of associated genes may facilitate the discovery of therapeutic targets. The prediction of an individual's disease risk allows for improved stratification and personalized prevention measures. Given the vast amount of genomic data, artificial intelligence, as a burgeoning technology for data analysis, is poised to make a significant impact in genomics.
What problem does this paper attempt to address?